(0.82%) 5 475.98 points
(0.38%) 38 738 points
(1.09%) 17 881 points
(1.80%) $79.86
(-3.40%) $2.78
(-0.79%) $2 330.60
(-0.31%) $29.38
(1.41%) $972.10
(-0.14%) $0.932
(0.09%) $10.68
(-0.11%) $0.787
(-1.25%) $88.47
Live Chart Being Loaded With Signals
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company\'s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia...
Stats | |
---|---|
本日の出来高 | 1 579 |
平均出来高 | 12 342 |
時価総額 | 12.11M |
EPS | $-0.910 ( Q1 | 2024-05-09 ) |
次の収益日 | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.450 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0700 (3.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Wool Kyle Michael | Buy | 154 559 | Common Stock |
2024-06-11 | Hayes Anthony | Buy | 154 559 | Common Stock |
2024-05-30 | Hayes Anthony | Buy | 3 482 | Common Stock |
2024-05-29 | Hayes Anthony | Buy | 1 158 | Common Stock |
2024-05-29 | Wool Kyle Michael | Buy | 5 000 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 63 transactions |
Buy: 1 831 956 | Sell: 0 |
Dominari Holdings Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Dominari Holdings Inc. 財務諸表
Annual | 2023 |
収益: | $2.04M |
総利益: | $1.60M (78.32 %) |
EPS: | $-4.38 |
FY | 2023 |
収益: | $2.04M |
総利益: | $1.60M (78.32 %) |
EPS: | $-4.38 |
FY | 2022 |
収益: | $0 |
総利益: | $188 000 (0.00 %) |
EPS: | $-7.23 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-1.530 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Dominari Holdings Inc.
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company\'s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。